Foam Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Foam Granulation
The authors review developments in wet granulation using a twin-screw extruder.


Pharmaceutical Technology
Volume 37, Issue 3, pp. 68-72

References

1. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Drug Dev. Ind. Pharm. 30 (6) 679-691 (2004).

2. L. Tan, A.J. Carella, Y. Ren, and J.B. Lo, Pharm. Dev. Tech. 16 (4) 302-315 (2011).

3. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 239 (1-2) 69-80 (2002).

4. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 273 (1-2) 183-194 (2004).

5. D. Djuric and P. Kleinebudde, J. Pharm. Sci. 97 (11) 4934-4942 (2008).

6. M.R. Thompson, S. Weatherley, R.N. Pukadyil, and P.J. Sheskey, Drug Dev. Ind. Pharm. 38 (7) 771-784 (2012).

7. W. Thiele, "Twin-Screw Extrusion and Screw Design," in Pharmaceutical Extrusion Technology, I. Ghebre-Sellassie and C. Martin, Eds. (Marcel Dekker, New York, NY, 2003), pp. 69-98.

8. D. Djuric, et al., Eur. J. Pharm. Biopharm. 71 (1) 155-160 (2009).

9. M.R. Thompson and J. Sun, J. Pharm. Sci. 99 (4) 2090-2103 (2010).

10. R.M. Dhenge, et al., Pow. Tech., DOI: 10.1016/j.powtec.2012.05.045, May 29, 2012.

11. U. Shah, Pharm. Tech. 29 (6) 52-66 (2005).

12. B. Van Melkebeke, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 356 (1-2) 224-230 (2008).

13. N.O. Lindberg, C. Tufvesson, P. Holm, and L. Olbjer, Drug Dev. Ind. Pharm. 14 (13) 1791-1798 (1988).

14. M.R. Thompson, B. Mu, and P.J. Sheskey, Pow. Tech., 228, 339-348 (2012).

15. C.M. Keary and P.J. Sheskey, Drug Dev. Ind. Pharm., 30 (8) 831-845 (2004).

16. M.X.L. Tan, L.S. Wong, K.H. Lum, and K.P. Hapgood, Chem. Eng. Sci., 64 (12) 2826-2836 (2009).

17. M.X.L. Tan and K.P. Hapgood, Pow. Tech., 218, 149-156 (2012).

18. S.L. Cantor, S. Kothari, and O.M.Y. Koo, Pow. Tech., 195, 15-24 (2009).

19. P. Sheskey, C. Keary, D. Clark, and K. Balwinski, Pharm. Tech., 31 (4) 94-108 (2007).

20. M.X.L. Tan and K.P. Hapgood, Chem. Eng. Res. Des. 89 (5) 526-536 (2011).

21. M.X.L. Tan and K.P. Hapgood, Chem. Eng. Sci. 66 (21) 5204-5211 (2011).

Michael R. Thompson* is an associate professor in the Department of Chemical Engineering at McMaster University, Hamilton, Ontario, L8S 4L7, Canada, Tel: 905.525.9140,
, and Paul J. Sheskey is a principal research scientist at Larkin Laboratory, The Dow Chemical Company, Midland, Michigan.

*To whom all correspondence should be addressed.

Submitted: Sept. 6, 2012. Accepted: Sept. 28, 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here